Stockscreener 앱 받기
57.33
2.76%
-1.5203
Crispr Therapeutics Ag 주식(CRSP)의 최신 뉴스
50,250 Shares in CRISPR Therapeutics AG $CRSP Purchased by Philadelphia Trust Co. - MarketBeat
Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown - MSN
Will CRISPR Therapeutics AG (1CG) stock return to pre crash levelsWeekly Trade Report & Weekly High Potential Stock Alerts - Newser
Is CRISPR Therapeutics AG stock a bargain at current levelsJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Cathie Wood’s Buys And Rumors Aside, Here’s Why Crispr Therapeutics Is A Strong Buy (CRSP) - Seeking Alpha
Rhumbline Advisers Buys New Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Nasdaq Index Biotech Momentum - Kalkine Media
Bernstein Reaffirms Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail
Will CRISPR Therapeutics AG stock continue upward momentumLayoff News & Weekly Top Stock Performers List - Newser
Can CRISPR Therapeutics AG (1CG) stock deliver double digit returnsMarket Volume Summary & Long Hold Capital Preservation Tips - Newser
How dovish Fed policy supports CRISPR Therapeutics AG (1CG) stockJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - Newser
Will CRISPR Therapeutics AG (1CG) stock outperform benchmarksMarket Sentiment Summary & High Conviction Buy Zone Picks - Newser
Will CRISPR Therapeutics AG (1CG) stock outperform value peers2025 Price Targets & High Accuracy Trade Alerts - Newser
Will CRISPR Therapeutics AG (1CG) stock hit analyst forecastsMarket Sentiment Summary & AI Based Trade Execution Alerts - Newser
CRISPR Therapeutics: CTX310 De-Risks, CASGEVY Disappoints Amid Takeover Rumors (CRSP) - Seeking Alpha
The Best CRISPR Companies for 2025 - The Motley Fool
Crispr Therapeutics (CRSP) Gains Amid Takeover Speculation - GuruFocus
Crispr Therapeutics pares loss amid takeover speculation (CRSP:NASDAQ) - Seeking Alpha
Inflation Data: Can SGBX stock maintain operating marginsMarket Performance Recap & Detailed Earnings Play Alerts - BỘ NỘI VỤ
Crispr Therapeutics (CRSP) Shares React to M&A Rumor - GuruFocus
Crispr Therapeutics rumor highlighted in Betaville blog - TipRanks
Loomis Sayles & Co. L P Has $41.68 Million Stock Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat
What CRISPR Therapeutics’ (CRSP) Latest Trial Results Mean for Investors - MSN
West Family Investments Inc. Takes Position in CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics AG $CRSP Shares Sold by Cetera Investment Advisers - MarketBeat
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% - The Motley Fool
Ameritas Investment Partners Inc. Purchases Shares of 8,451 CRISPR Therapeutics AG $CRSP - MarketBeat
Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy - Insider Monkey
CRISPR Therapeutics (CRSP): Assessing Valuation in Light of Recent Share Price Volatility - Yahoo Finance
Why CRISPR Therapeutics AG (1CG) stock could be next leaderWeekly Investment Summary & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Why CRISPR Therapeutics (CRSP) Is Up 6.1% After Positive CTX310 Trial and Earnings Beat - Sahm
Price-Driven Insight from (CRSP) for Rule-Based Strategy - news.stocktradersdaily.com
CRISPR Therapeutics (CRSP): Exploring Valuation After Analyst Upgrades and Q3 Clinical Progress - Sahm
Himension Capital Singapore PTE. LTD. Sells 10,454 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
Magnetar Financial LLC Invests $319,000 in CRISPR Therapeutics AG $CRSP - MarketBeat
Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (PMN) and Crispr Therapeutics AG (CRSP) - The Globe and Mail
Chardan Capital Lowers Price Target for CRSP Despite Buy Rating - GuruFocus
Chardan Cuts Price Target on CRISPR Therapeutics to $74 From $82, Keeps Buy Rating - MarketScreener
Crispr Therapeutics price target lowered to $74 from $82 at Chardan - TipRanks
Aug PreEarnings: Is CRISPR Therapeutics AG stock positioned for long term growthJuly 2025 Pullbacks & Real-Time Market Sentiment Reports - BỘ NỘI VỤ
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com
RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50, Keeps Sector Perform - MSN
Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance - MSN
Police & Firemen s Retirement System of New Jersey Makes New $911,000 Investment in CRISPR Therapeutics AG $CRSP - MarketBeat
Entropy Technologies LP Invests $1.06 Million in CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics Hits Day High with 8.24% Surge in Stock Price - Markets Mojo
9 Oversold Biotech Stocks to Invest In - Insider Monkey
CRISPR Therapeutics Hits Day Low at $48.24 Amid Price Pressure - Markets Mojo
Does the Pullback Signal Opportunity for CRISPR Therapeutics After Gene Editing Approval? - Yahoo Finance
Intech Investment Management LLC Makes New $1.90 Million Investment in CRISPR Therapeutics AG $CRSP - MarketBeat
Del Sette Capital Management LLC Buys New Holdings in CRISPR Therapeutics AG $CRSP - MarketBeat
How the First CRISPR-Based Therapy Approval Impacts CRISPR Therapeutics’ Valuation - Sahm
0.46%
1.57%
자본화:
|
볼륨(24시간):